Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.

A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors

1989 • 1,471 citations

Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic Cancer

1992 • 689 citations

Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

1994 • 517 citations

The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast Cancer

1988 • 424 citations

Cardiac and Thromboembolic Morbidity Among Postmenopausal Women With Early Stage Breast Cancer in a Randomized Trial of Adjuvant Tamoxifen

1993 • 339 citations

Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.

1990 • 296 citations

Vascular toxicity associated with antineoplastic agents.

1986 • 231 citations

Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen

1984 • 202 citations

Elevated Plasma von Willebrand Factor Levels and Arterial Occlusive Complications Associated with Cisplatin-Based Chemotherapy

1985 • 189 citations

Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience.

1989 • 152 citations

Chemotherapy for breast cancer decreases plasma protein C and protein S.

1988 • 150 citations

Long-term adjuvant therapy with tamoxifen: effects on sex hormone binding globulin and antithrombin III.

1987 • 124 citations

Effects of chemotherapeutic drugs on platelet and metastatic tumor cell-endothelial cell interactions as a model for assessing vascular endothelial integrity.

1985 • 121 citations

Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study.

1994 • 112 citations

Venous thrombosis as a side effect of tamoxifen treatment.

1984 • 107 citations

Venous thrombosis during multimodal treatment of primary breast carcinoma.

1981 • 106 citations

Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: A cancer and leukemia group B study

1989 • 85 citations

Chemotherapy enhances endothelial cell reactivity to platelets

1990 • 77 citations

The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up

1994 • 65 citations

Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (breast cancer adjuvant chemo-hormone therapy cooperative group) trial

1992 • 60 citations

The influence of chemotherapy on plasma coagulation and fibrinolytic systems in lung cancer patients

1989 • 47 citations

Hypercoagulable state induced by cytostatic drugs in stage ii breast cancer patients

1986 • 44 citations

Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal women

1992 • 41 citations

ADJUVANT TAMOXIFEN IN BREAST-CANCER-TREATMENT IN POSTMENOPAUSAL WOMEN - OCCURRENCE OF THROMBOEMBOLIC COMPLICATIONS

1994 • 22 citations

Adjuvant chemotherapy and venous thrombosis

1982 • 2 citations

Cited By (0)

Loading...